Annual TB Conference – The Union NAR
The Union-North America Region (NAR) is the regional arm of the International Union against Tuberculosis and Lung Disease (The Union), a global public health organization with the vision to provide health solutions to the poor. BC Lung is an organizational member of The Union and acts as the Secretariat, organizing and hosting The Union-NAR's annual conference in consultation with the Executive Committee.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Curry International Tuberculosis Center and The Union North America Region. Curry International Tuberculosis Center is accredited by the ACCME to provide continuing medical education for physicians. This educational conference is approved for 18.0 continuing education hours.
The Curry International Tuberculosis Center designates this educational activity for a maximum of 18.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses, Provider Number CEP 12308. This educational activity is approved for 18.0 continuing education hours. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the educational conference or leave the educational conference early. Therefore, partial credit will not be awarded.
End TB 2025
February 26 to March 1, 2025
29th Annual Conference of Union-North America Region
Sheraton Wall Centre Hotel, Vancouver BC
1000 Burrard St, Vancouver, BC V6Z 2R9
Phone: (604) 331-1000
Book your group rate before January 27, 2025 by clicking here.
2025 Call For Nominations
Submission Deadline is December 30, 2024
The North America Region of The Union is calling for Nominations for its Awards. Each year, at the time of our annual meeting we recognize the valuable contributions of our colleagues to tuberculosis (TB) care and prevention.
President-Elect
Lifetime Achievement & Service Awards
Early Career Investigator Award
Call for Late Breaker Abstracts
Deadline for Submissions: December 27, 2024
We welcome the submission of abstracts for poster and oral presentations of research on all aspects of tuberculosis prevention and care, including epidemiologic, clinical, basic science, nursing, social, behavioural, psychosocial, and educational studies, as well as outcomes of program initiatives. We also welcome abstracts on topics other than tuberculosis, including COVID-19 and smoking cessation. Abstracts must be submitted in accordance with these guidelines.
More…
As in previous years, high-scoring abstracts, with relevancy for the symposium session themes, will be identified, and invited to provide a 5-7minute oral presentation during the conference.
If your abstract is selected for this opportunity, this is in addition to a poster abstract presentation.
Oral and Poster Presentations
- You may request 1) poster presentation only, or 2) possible invitation for oral presentation according to score. (Note: The decision to extend an invitation for an oral presentation is based primarily on the score an abstract earns and its contributions of new programmatic or scientific knowledge relating to the plenary agenda.)
- All abstracts submitted will be reviewed.
- The highest-ranked abstracts will be considered for oral presentation and others for poster presentation.
- Abstracts of limited quality and those lacking results will not be accepted.
Abstract Content
- Abstracts may be written in English, French or Spanish however, we encourage Posters to be in English.
- Abstracts must be:
-
- maximum of 250 words, excluding title, headings, and authors’ names and affiliations
-
- The body of the abstract should contain the following sections (Note: section names should be included in the abstract, and written in all CAPITAL LETTERS):
-
- TITLE
- AUTHORS (last names and initials only, omit degrees), institutions, city, country (omit street address and zip/postal code); underline the name of presenting author
- BACKGROUND
- DESIGN/METHODS or INTERVENTION/RESPONSE
- RESULTS (Give both numbers and proportions where applicable)
- CONCLUSION
Abstracts may involve scientific research or public health practice, as described by The Union:
Category 1: Scientific research
It is recommended that the abstracts in Category 1 be organized using the following sections:
- Background: State study objectives, study question or a description of the challenge addressed by the resea
- Design/Methods: State the setting, methods, desired outcomes, procedures and techniques used to collect and analyze inform Include a description of participants, procedures, measures and appropriate statistical analyses.
- Results: Present specific findings to
- Conclusion and recommendations: State the implications of the results and key reco Present specific findings on how the research addressed the study, question or challenge. Highlight opportunities for future research as well as implications for further research for TB prevention and care programs.
Category 2: Public health practice /education and training
It is recommended that the abstracts in Category 2 be organized using the following sections (if an abstract cannot address these sections, it is likely not eligible for submission):
- Background and reason for implementation or problem being addressed: identify the context and the specific challenges to program imple Describe the activity, program or policy by which the issue was addressed. Describe target populations, geographic sites/locations and scale and type of activity or service.
- Intervention or response: how was the challenge overcome? Detail the methods, activities and implementation steps used to overcome the challe Describe the methods, procedures and techniques used to collect and analyze information that informed your conclusions. Identify the course of action used to address program implementation issues.
- Results and lessons learned: describe the results and impact of the p Explain the potential application or benefit to other programs. Describe what worked and what did not work and the evidence that led to this determination.
- Conclusions and key recommendations: state the implications of the effective public health practice and key recommendation
- Highlight opportunities for future program practice, as well as implications for other programs or settings.
Abstract Scoring Criteria
A NEW scoring rubric will be used this year!
The following rubric will be used to score the abstracts for the 2025 TB Conference:
- Relevance (Weight 1.0) — 0-5 points
- Methods/Intervention or Response (Weight 1.0) — 0-5 points
- Results/Impact (Weight 1.0) — 0-5 points
- Clarity of the Message (Weight 0.5) — 0-5 points
- Originality (Weight 0.5) — 0-5 points
Total: 20 points
Abstracts will be reviewed and accepted on the basis of on-time receipt, originality, quality of content, appropriate use of methodology, and relevance to TB control, prevention, and elimination, as determined by the abstract committee members.
Abstracts that Do Not Adhere to the Required Format and Word Limit Will be Excluded from Consideration.
Notification:
The submitting authors will be notified about abstract acceptance no later than Wednesday, January 14, 2025.
Abstracts may be accepted as submitted, or conditionally, based on the review and score received. If accepted on a conditional basis, we will contact you with instructions for the revisions needed or to provide technical assistance to improve the submission.
Submission
To submit click here: http://www.cvent.com/c/abstracts/52afa6ef-31f3-46a6-9993-31530e87028d
For more information contact: Menn Biagtan at biagtan@bclung.ca or Matthew Wong at mwong@bclung.ca
Annual TB Conference 2024
April 16-19, 2024 | Baltimore, MD
This year’s conference explored recent global and local epidemiology, efforts to prevent, and ultimately eliminate TB, advances in diagnostics and treatment regimens, proposed changes to the way we approach isolation practices, and – after treatment has concluded, the longer-term implications of tuberculosis which we are beginning to better understand.
The conference reconfirms the important contributions made by all professional sectors working in tuberculosis and the essential partnership of TB patients, their families, and survivors with public health programs, academic research settings, and treatment settings.
Previous Conference Archive
NAR Charter
This charter governs the North America Region (NAR) established by the General Assembly of the International Union Against Tuberculosis and Lung Disease (The Union).